Chemours Announces First Quarter Dividend
Get Alerts CC Hot Sheet
Join SI Premium – FREE
WILMINGTON, Del., Feb. 12, 2020 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in fluoroproducts, titanium technologies, and chemical solutions, announced today that the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the company's common stock for the first quarter of 2020. The dividend will be paid on March 16, 2020 to stockholders of record as of the close of business on February 27, 2020.
About The Chemours CompanyThe Chemours Company (NYSE: CC) is a global leader in titanium technologies, fluoroproducts, and chemical solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining, and general industrial manufacturing. Our flagship products include prominent brands such as Teflon™, Ti-Pure™, Krytox™, Viton™, Opteon™, Freon™ and Nafion™. In 2019, Chemours was named to Newsweek's list of America's Most Responsible Companies. The company has approximately 7,000 employees and 28 manufacturing sites serving approximately 3,700 customers in over 120 countries. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC.
For more information, we invite you to visit chemours.com or follow us on Twitter @Chemours or LinkedIn.

CONTACT:
INVESTORS Jonathan Lock VP, Corporate Development and Investor Relations +1.302.773.2263 [email protected]
NEWS MEDIA David RosenGlobal Leader, Media Relations and Strategic Communications+1.302.773.2711[email protected]
View original content to download multimedia:http://www.prnewswire.com/news-releases/chemours-announces-first-quarter-dividend-301003998.html
SOURCE The Chemours Company
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chemours reaches $450M settlement over PFAS pollution at four sites
- Kadima Neuropsychiatry Institute Files Suit Against NRx Pharmaceuticals (NASDAQ: NRXP), Alleging Breach of Contract and Misrepresentation in Connection with Acquisition
- Train Your Skin Like You Train Your Body: LifeSpa at Life Time Brings a Training Mindset to Summer Skincare
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Twitter, DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share